Education

Site Preparation for Establishing 177Lu-Radioligand Therapy Programs



There's a New PET Drug in Town: Manufacturing and Approval Consideration
for Your Institution


Theranostics: Regulatory Considerations for Product Development


SNMMI/NCI Third Targeted Radionuclide Therapy Conference 2019

Guidance Documents

• Joint EANM/SNMMI Procedure Guideline for the Use of 177Lu-Labeled PSMA-Targeted Radioligand-Therapy (177Lu-PSMA-RLT) – May 2023
    
• PSMA PET/CT: Joint EANM Procedure Guideline/SNMMI Procedure Standard for Prostate Cancer Imaging 2.0 – January 2023
   
• 68Ga-PSMA PET/CT: Prostate Cancer Imaging: version 1.0 – March 2017
   
• Charging for Investigational Drugs Under an IND — Questions and Answers
  Guidance for Industry – June 2016
   
• Expanded Access to Investigational Drugs for Treatment Use — Questions and Answers
  Guidance for Industry – June 2016

Appropriate Use Criteria

• SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177Lu-PSMA-617 Radionuclide Therapy – April 2023
  
  
• Prostate-Specific Membrane Antigen (PSMA) PET Imaging – September 2021
  • Printer-Friendly Fact Sheet (PDF)
  • Video: Dr. Hossein Jadvar discusses the AUC for PSMA PET imaging
    
    
• Somatostatin Receptor–Based Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE – September 2017
  • Printer-Friendly Fact Sheet (PDF)

Therapy Implementation Checklist

• Radiopharmaceutical Therapy Toolkit Checklist (PDF)
• Radiopharmaceutical Therapy Toolkit Checklist (MS Word)

Tools for Technologists

Publications

• Guidance on 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy from the Experience of a Single Nuclear Medicine Division
   
• SNMMI Clinical Trials Network (CTN) Research Series for Technologists: “Clinical Research Primer – Regulatory Process Part I: How and when Radiopharmaceuticals Can be Used”
   
• For more articles on nuclear medicine therapy from SNMMI journals, click here.

Useful Links

• DOE Isotope Production website
   
• National Isotope Development Center (NIDC) website
   
• Sign-up for the NIDC mailing list